Scientists are also targeting metabolic functions beyond cholesterol, because the brain handles energy differently as Alzheimers disease develops
PS-PLA 1 preferentially hydrolyzes phosphatidylserine (PS) hence the naming of this enzyme
Semaglutide remains the best-tolerated option at 6.9% discontinuation
Researchers reveal benefits, risks linked to popular weight-loss drugs GLP-1 receptor agonists transform diabetes care, offering benefits to heart and brain health but posing risks to kidneys and pancreas Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart disease, and obesity
Chronic low-grade inflammation is increasingly recognised as a key contributor to numerous conditions, including cardiovascular disease, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and certain autoimmune disorders
Science 384 , eadh3707 (2024)